Literature DB >> 11394195

Bipolar disorder after mefloquine treatment.

C Even, S Friedman, K Lanouar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11394195      PMCID： PMC1408302     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  4 in total

Review 1.  Travel medicine--prevention based on epidemiological data.

Authors:  R Steffen
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

2.  Neuropsychiatric side effects of mefloquine.

Authors:  D Stürchler; J Handschin; D Kaiser; L Kerr; M L Mittelholzer; R Reber; M Fernex
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

Review 3.  Calcium channel blockers in psychiatric disorders: a review of the literature.

Authors:  L E Hollister; E S Trevino
Journal:  Can J Psychiatry       Date:  1999-09       Impact factor: 4.356

4.  Neuropsychiatric reactions with mefloquine chemoprophylaxis.

Authors:  A M Croft; M J World
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321
  4 in total
  4 in total

1.  Anti-malaria drug mefloquine induces motor learning deficits in humans.

Authors:  Thomas A van Essen; Ruben S van der Giessen; Sebastiaan K E Koekkoek; Frans Vanderwerf; Chris I De Zeeuw; Perry J J van Genderen; David Overbosch; Marcel T G de Jeu
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

2.  Association analysis of HSP90B1 with bipolar disorder.

Authors:  Chihiro Kakiuchi; Mizuho Ishiwata; Shinichiro Nanko; Hiroshi Kunugi; Yoshio Minabe; Kazuhiko Nakamura; Norio Mori; Kumiko Fujii; Tadashi Umekage; Mamoru Tochigi; Kazuhisa Kohda; Tsukasa Sasaki; Kazuo Yamada; Takeo Yoshikawa; Tadafumi Kato
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

Review 3.  Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force.

Authors:  Stuart McCarthy
Journal:  J Parasitol Res       Date:  2015-12-17

4.  Behavioral effects of mefloquine in tail suspension and light/dark tests.

Authors:  John Michael Holden; Richard Slivicki; Rachel Dahl; Xia Dong; Matt Dwyer; Weston Holley; Crissa Knott
Journal:  Springerplus       Date:  2015-11-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.